{"protocolSection":{"identificationModule":{"nctId":"NCT00527943","orgStudyIdInfo":{"id":"P04736"},"secondaryIdInfos":[{"id":"TRA•CER"},{"id":"2006-002809-31"},{"id":"MK-5348-014","type":"OTHER","domain":"Merck Study Number"}],"organization":{"fullName":"Merck Sharp & Dohme LLC","class":"INDUSTRY"},"briefTitle":"Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER)"},"statusModule":{"statusVerifiedDate":"2018-08","overallStatus":"TERMINATED","whyStopped":"The trial was terminated at the request of the Data and Safety Monitoring Board.","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2007-12-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2011-07-01","type":"ACTUAL"},"completionDateStruct":{"date":"2011-07-01","type":"ACTUAL"},"studyFirstSubmitDate":"2007-09-07","studyFirstSubmitQcDate":"2007-09-07","studyFirstPostDateStruct":{"date":"2007-09-11","type":"ESTIMATED"},"resultsFirstSubmitDate":"2014-05-09","resultsFirstSubmitQcDate":"2014-05-09","resultsFirstPostDateStruct":{"date":"2014-06-09","type":"ESTIMATED"},"lastUpdateSubmitDate":"2018-08-22","lastUpdatePostDateStruct":{"date":"2018-09-21","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Merck Sharp & Dohme LLC","class":"INDUSTRY"},"collaborators":[{"name":"Duke Clinical Research Institute","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The study is designed to determine whether vorapaxar, when added to the existing standard of care (eg, aspirin, clopidogrel) for preventing heart attack and stroke in patients with acute coronary syndrome, will yield additional benefit over the existing standard of care in preventing heart attack and stroke.\n\nThe study is also designed to assess risk of bleeding with vorapaxar added to the standard of care versus the standard of care alone."},"conditionsModule":{"conditions":["Atherosclerosis","Myocardial Ischemia","Myocardial Infarction"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"TRIPLE","whoMasked":["PARTICIPANT","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":12944,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care.","interventionNames":["Drug: Placebo"]},{"label":"Vorapaxar","type":"EXPERIMENTAL","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care.","interventionNames":["Drug: Vorapaxar"]}],"interventions":[{"type":"DRUG","name":"Vorapaxar","description":"oral tablets; 40-mg loading dose on first day, followed by 2.5 mg once daily for at least 1 year","armGroupLabels":["Vorapaxar"],"otherNames":["SCH 530348","MK-5348"]},{"type":"DRUG","name":"Placebo","description":"oral tablets; matching placebo for vorapaxar; loading and maintenance dosing; once daily for at least 1 year","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced Cardiovascular Death, Myocardial Infarction, Stroke, Recurrent Ischemia With Re-hospitalization, and/or Urgent Coronary Revascularization Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: cardiovascular (CV) death, myocardial infarction (MI), stroke, recurrent ischemia with re-hospitalization (RIR), and/or urgent coronary revascularization (UCR). A Clinical Endpoints Committee (CEC) reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced at least 1 of the components of the primary composite efficacy endpoint within 2 years from randomization.","timeFrame":"Up to 2 years"}],"secondaryOutcomes":[{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced Cardiovascular Death, Myocardial Infarction, and/or Stroke Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: cardiovascular (CV) death, myocardial infarction (MI), and/or stroke. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced at least 1 of the components of the secondary composite efficacy endpoint within 2 years from randomization.","timeFrame":"up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Met Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) Moderate or Severe Bleeding Criteria Within 2 Years From Randomization","description":"Adverse events were categorized as \"bleeding events\" if the intensity of the event was other or more than would be normally expected in the given situation (eg, mild nosebleed in a person who does not normally have nosebleeds, greater bruising than expected for a given injury, greater volume of blood loss than expected for a given procedure). The investigator graded the intensity of bleeding events according to the GUSTO cooperative group criteria as follows: Mild , Moderate or Severe and the grading was adjudicated by the CEC. The Kaplan-Meier estimate reports the percentage of participants who experienced GUSTO moderate or severe bleeding within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced Clinically Significant Bleeding Within 2 Years From Randomization","description":"Adverse events were categorized as \"bleeding events\" if the intensity of the event was other or more than would be normally expected in the given situation (eg, mild nosebleed in a person who does not normally have nosebleeds, greater bruising than expected for a given injury, greater volume of blood loss than expected for a given procedure). The investigator graded the intensity of bleeding events according to the Thrombolysis in Myocardial Infarction (TIMI) Study Group criteria as major, minor or other. \"Clinically Significant Bleeding\" was defined as the composite of TIMI Major bleeding, TIMI Minor bleeding, or bleeding that required unplanned medical or surgical treatment or unplanned laboratory evaluation even if it did not meet the criteria for TIMI major or minor bleeding. The Kaplan-Meier estimate reports the percentage of participants who experienced clinically significant bleeding within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced CV Death, MI, Stroke, or UCR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: CV death, MI, stroke, or UCR. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced CV death, MI, stroke, or UCR within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced CV Death or MI Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: CV death or MI. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced CV death or MI within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced All-cause Death, MI, Stroke, RIR, or UCR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: all-cause death, MI, stroke, RIR, or UCR. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). The Kaplan-Meier estimate reports the percentage of participants who experienced all-cause death, MI, stroke, RIR, or UCR within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced All-cause Death, MI, Stroke, or UCR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: all-cause death, MI, stroke, or UCR. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). The Kaplan-Meier estimate reports the percentage of participants who experienced all-cause Death, MI, stroke, or UCR I within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced CV Death Within 2 Years From Randomization","description":"The time (in days) from study start to the CV death (if reported) was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced CV death within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced an MI Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of an MI was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced an MI within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced RIR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of RIR was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced RIR within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced UCR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of UCR was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced UCR within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Died From Any Cause Within 2 Years From Randomization","description":"The time (in days) from study start to death from any cause was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). The Kaplan-Meier estimate reports the percentage of participants who died from any cause within 2 years from randomization.","timeFrame":"Up to 2 years"},{"measure":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced a Stroke Within 2 Years From Randomization","description":"The time (in days) from study start to first experience of a stroke was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced a stroke within 2 years from randomization.","timeFrame":"Up to 2 years"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\nMen and women at least 18 years old with current clinical manifestation of non-ST-segment-elevation myocardial infarction (heart attack) according to the following three criteria:\n\n* current symptoms of cardiac ischemia (chest pain leading to cardiac ischemia or heart attack)\n\nAND\n\n* either of the following:\n\n  * concurrent elevation of troponin I or T, or of creatine kinase - myocardial band (CK-MB) to a level above the upper limit of normal, OR\n  * concurrent appropriate electrocardiographic evidence\n\nAND\n\n* any one (or more) of the following:\n\n  * age \\>= 55 years\n  * documented history of prior heart attack or coronary revascularization (eg, angioplasty \\[PCI\\], coronary artery replacement \\[CABG\\])\n  * diabetes (documented use of insulin or oral hypoglycemic\\[s\\])\n  * documented history of peripheral arterial disease\n\nExclusion Criteria:\n\n* history of intracranial hemorrhage or of central nervous system (CNS) surgery, tumor, or aneurysm\n* any bleeding disorder or abnormality\n* sustained severe hypertension or valvular heart disease\n* current or recent platelet count \\<100,000 mm\\^3\n* planned or ongoing treatment with a blood thinning medication\n* pregnancy\n* any significant medical or physiological condition or abnormality that could put the subject at increased risk or limit the subject's ability to participate for the duration of the study","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"referencesModule":{"references":[{"pmid":"24402559","type":"RESULT","citation":"Storey RF, Kotha J, Smyth SS, Moliterno DJ, Rorick TL, Moccetti T, Valgimigli M, Dery JP, Cornel JH, Thomas GS, Huber K, Harrington RA, Hord E, Judge HM, Chen E, Strony J, Mahaffey KW, Tricoci P, Becker RC, Jennings LK. Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes. The TRACER Pharmacodynamic Substudy. Thromb Haemost. 2014 May 5;111(5):883-91. doi: 10.1160/TH13-07-0624. Epub 2014 Jan 9."},{"pmid":"25129064","type":"RESULT","citation":"Valgimigli M, Tricoci P, Huang Z, Aylward PE, Armstrong PW, Van de Werf F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, Mahaffey KW, Moliterno DJ. Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial). Am J Cardiol. 2014 Sep 1;114(5):665-73. doi: 10.1016/j.amjcard.2014.05.054. Epub 2014 Jun 18."},{"pmid":"36302586","type":"DERIVED","citation":"Batra G, Lindback J, Becker RC, Harrington RA, Held C, James SK, Kempf T, Lopes RD, Mahaffey KW, Steg PG, Storey RF, Swahn E, Wollert KC, Siegbahn A, Wallentin L. Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary Syndromes. J Am Coll Cardiol. 2022 Nov 1;80(18):1735-1747. doi: 10.1016/j.jacc.2022.08.767."},{"pmid":"35224730","type":"DERIVED","citation":"Natale P, Palmer SC, Saglimbene VM, Ruospo M, Razavian M, Craig JC, Jardine MJ, Webster AC, Strippoli GF. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev. 2022 Feb 28;2(2):CD008834. doi: 10.1002/14651858.CD008834.pub4."},{"pmid":"29910052","type":"DERIVED","citation":"Inohara T, Pieper K, Wojdyla DM, Patel MR, Jones WS, Tricoci P, Mahaffey KW, James SK, Alexander JH, Lopes RD, Wallentin L, Ohman EM, Roe MT, Vemulapalli S. Incidence, timing, and type of first and recurrent ischemic events in patients with and without peripheral artery disease after an acute coronary syndrome. Am Heart J. 2018 Jul;201:25-32. doi: 10.1016/j.ahj.2018.03.013. Epub 2018 Mar 28."},{"pmid":"27502866","type":"DERIVED","citation":"Armaganijan LV, Alexander KP, Huang Z, Tricoci P, Held C, Van de Werf F, Armstrong PW, Aylward PE, White HD, Moliterno DJ, Wallentin L, Chen E, Harrington RA, Strony J, Mahaffey KW, Lopes RD. Effect of age on efficacy and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. Am Heart J. 2016 Aug;178:176-84. doi: 10.1016/j.ahj.2016.05.012. Epub 2016 Jun 9."},{"pmid":"27162212","type":"DERIVED","citation":"Popma CJ, Sheng S, Korjian S, Daaboul Y, Chi G, Tricoci P, Huang Z, Moliterno DJ, White HD, Van de Werf F, Harrington RA, Wallentin L, Held C, Armstrong PW, Aylward PE, Strony J, Mahaffey KW, Gibson CM. Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy. Circ Cardiovasc Interv. 2016 May;9(5):e003114. doi: 10.1161/CIRCINTERVENTIONS.115.003114."},{"pmid":"27151345","type":"DERIVED","citation":"Vranckx P, White HD, Huang Z, Mahaffey KW, Armstrong PW, Van de Werf F, Moliterno DJ, Wallentin L, Held C, Aylward PE, Cornel JH, Bode C, Huber K, Nicolau JC, Ruzyllo W, Harrington RA, Tricoci P. Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial. J Am Coll Cardiol. 2016 May 10;67(18):2135-2144. doi: 10.1016/j.jacc.2016.02.056."},{"pmid":"26089177","type":"DERIVED","citation":"Mahaffey KW, Hager R, Wojdyla D, White HD, Armstrong PW, Alexander JH, Tricoci P, Lopes RD, Ohman EM, Roe MT, Harrington RA, Wallentin L. Meta-analysis of intracranial hemorrhage in acute coronary syndromes: incidence, predictors, and clinical outcomes. J Am Heart Assoc. 2015 Jun 18;4(6):e001512. doi: 10.1161/JAHA.114.001512."},{"pmid":"26025218","type":"DERIVED","citation":"Bagai A, Huang Z, Lokhnygina Y, Harrington RA, Armstrong PW, Strony J, White HD, Leonardi S, Held C, Van de Werf F, Wallentin L, Tricoci P, Mahaffey KW. Magnitude of troponin elevation and long-term clinical outcomes in acute coronary syndrome patients treated with and without revascularization. Circ Cardiovasc Interv. 2015 Jun;8(6):e002314. doi: 10.1161/CIRCINTERVENTIONS.115.002314."},{"pmid":"25012288","type":"DERIVED","citation":"White HD, Huang Z, Tricoci P, Van de Werf F, Wallentin L, Lokhnygina Y, Moliterno DJ, Aylward PE, Mahaffey KW, Armstrong PW. Reduction in overall occurrences of ischemic events with vorapaxar: results from TRACER. J Am Heart Assoc. 2014 Jul 10;3(4):e001032. doi: 10.1161/JAHA.114.001032."},{"pmid":"24211500","type":"DERIVED","citation":"Whellan DJ, Tricoci P, Chen E, Huang Z, Leibowitz D, Vranckx P, Marhefka GD, Held C, Nicolau JC, Storey RF, Ruzyllo W, Huber K, Sinnaeve P, Weiss AT, Dery JP, Moliterno DJ, Van de Werf F, Aylward PE, White HD, Armstrong PW, Wallentin L, Strony J, Harrington RA, Mahaffey KW. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome). J Am Coll Cardiol. 2014 Mar 25;63(11):1048-57. doi: 10.1016/j.jacc.2013.10.048. Epub 2013 Nov 21."},{"pmid":"22077816","type":"DERIVED","citation":"Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW; TRACER Investigators. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13."},{"pmid":"19699853","type":"DERIVED","citation":"TRA*CER Executive and Steering Committees. The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale. Am Heart J. 2009 Sep;158(3):327-334.e4. doi: 10.1016/j.ahj.2009.07.001. Erratum In: Am Heart J. 2010 May;159(5):932."}],"availIpds":[{"type":"CSR Synopsis","url":"http://www.merck.com/clinical-trials/study.html?id=P04736&kw=P04736&tab=access"}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"https://www.merck.com/clinical-trials/pdf/ProcedureAccessClinicalTrialData.pdf","url":"http://engagezone.msd.com/ds_documentation.php"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"The Intent to Treat (ITT) Population, defined as all enrolled participants who were randomly assigned to a treatment group.","recruitmentDetails":"Prior to the planned study completion, the Data Safety Monitoring Board recommended that all participants stop treatment and that the study be closed-out. The protocol-defined target number of primary efficacy endpoints had been reached by this time. However, follow-up in the study was terminated earlier than planned.","groups":[{"id":"FG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"FG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"6471"},{"groupId":"FG001","numSubjects":"6473"}]},{"type":"Received Treatment","achievements":[{"groupId":"FG000","numSubjects":"6441"},{"groupId":"FG001","numSubjects":"6446"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"6311"},{"groupId":"FG001","numSubjects":"6327"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"160"},{"groupId":"FG001","numSubjects":"146"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"BG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"6471"},{"groupId":"BG001","value":"6473"},{"groupId":"BG002","value":"12944"}]}],"measures":[{"title":"Age, Customized","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"<65 years","categories":[{"measurements":[{"groupId":"BG000","value":"3369"},{"groupId":"BG001","value":"3390"},{"groupId":"BG002","value":"6759"}]}]},{"title":"65 to <75 years","categories":[{"measurements":[{"groupId":"BG000","value":"2006"},{"groupId":"BG001","value":"1973"},{"groupId":"BG002","value":"3979"}]}]},{"title":">= 75 years","categories":[{"measurements":[{"groupId":"BG000","value":"1096"},{"groupId":"BG001","value":"1110"},{"groupId":"BG002","value":"2206"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"1822"},{"groupId":"BG001","value":"1810"},{"groupId":"BG002","value":"3632"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"4649"},{"groupId":"BG001","value":"4663"},{"groupId":"BG002","value":"9312"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced Cardiovascular Death, Myocardial Infarction, Stroke, Recurrent Ischemia With Re-hospitalization, and/or Urgent Coronary Revascularization Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: cardiovascular (CV) death, myocardial infarction (MI), stroke, recurrent ischemia with re-hospitalization (RIR), and/or urgent coronary revascularization (UCR). A Clinical Endpoints Committee (CEC) reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced at least 1 of the components of the primary composite efficacy endpoint within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.9"},{"groupId":"OG001","value":"18.5"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.072","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"0.92","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.85","ciUpperLimit":"1.01","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced Cardiovascular Death, Myocardial Infarction, and/or Stroke Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: cardiovascular (CV) death, myocardial infarction (MI), and/or stroke. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced at least 1 of the components of the secondary composite efficacy endpoint within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16.4"},{"groupId":"OG001","value":"14.7"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.018","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"0.89","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.81","ciUpperLimit":"0.98","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Met Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) Moderate or Severe Bleeding Criteria Within 2 Years From Randomization","description":"Adverse events were categorized as \"bleeding events\" if the intensity of the event was other or more than would be normally expected in the given situation (eg, mild nosebleed in a person who does not normally have nosebleeds, greater bruising than expected for a given injury, greater volume of blood loss than expected for a given procedure). The investigator graded the intensity of bleeding events according to the GUSTO cooperative group criteria as follows: Mild , Moderate or Severe and the grading was adjudicated by the CEC. The Kaplan-Meier estimate reports the percentage of participants who experienced GUSTO moderate or severe bleeding within 2 years from randomization.","populationDescription":"As Treated Population, which included all participants who received at least 1 dose of study medication.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6441"},{"groupId":"OG001","value":"6446"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.8"},{"groupId":"OG001","value":"7.6"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"<0.001","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"1.36","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.18","ciUpperLimit":"1.57","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced Clinically Significant Bleeding Within 2 Years From Randomization","description":"Adverse events were categorized as \"bleeding events\" if the intensity of the event was other or more than would be normally expected in the given situation (eg, mild nosebleed in a person who does not normally have nosebleeds, greater bruising than expected for a given injury, greater volume of blood loss than expected for a given procedure). The investigator graded the intensity of bleeding events according to the Thrombolysis in Myocardial Infarction (TIMI) Study Group criteria as major, minor or other. \"Clinically Significant Bleeding\" was defined as the composite of TIMI Major bleeding, TIMI Minor bleeding, or bleeding that required unplanned medical or surgical treatment or unplanned laboratory evaluation even if it did not meet the criteria for TIMI major or minor bleeding. The Kaplan-Meier estimate reports the percentage of participants who experienced clinically significant bleeding within 2 years from randomization.","populationDescription":"As Treated Population, which included all participants who received at least 1 dose of study medication.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6441"},{"groupId":"OG001","value":"6446"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.6"},{"groupId":"OG001","value":"19.5"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"<0.001","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"1.41","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.29","ciUpperLimit":"1.54","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced CV Death, MI, Stroke, or UCR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: CV death, MI, stroke, or UCR. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced CV death, MI, stroke, or UCR within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19.2"},{"groupId":"OG001","value":"17.5"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.038","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"0.91","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.84","ciUpperLimit":"1.00","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced CV Death or MI Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: CV death or MI. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced CV death or MI within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14.9"},{"groupId":"OG001","value":"13.5"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.027","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"0.90","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.81","ciUpperLimit":"0.99","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced All-cause Death, MI, Stroke, RIR, or UCR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: all-cause death, MI, stroke, RIR, or UCR. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). The Kaplan-Meier estimate reports the percentage of participants who experienced all-cause death, MI, stroke, RIR, or UCR within 2 years from randomization.","populationDescription":"Intent to Treat population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.5"},{"groupId":"OG001","value":"20.6"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.174","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"0.94","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.87","ciUpperLimit":"1.03","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced All-cause Death, MI, Stroke, or UCR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of any of the following clinical outcomes was recorded: all-cause death, MI, stroke, or UCR. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). The Kaplan-Meier estimate reports the percentage of participants who experienced all-cause Death, MI, stroke, or UCR I within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20.8"},{"groupId":"OG001","value":"19.6"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.108","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"0.93","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.86","ciUpperLimit":"1.02","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced CV Death Within 2 Years From Randomization","description":"The time (in days) from study start to the CV death (if reported) was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced CV death within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.8"},{"groupId":"OG001","value":"3.8"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.963","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"1.00","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.83","ciUpperLimit":"1.22","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced an MI Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of an MI was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced an MI within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12.5"},{"groupId":"OG001","value":"11.1"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.021","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"0.88","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.79","ciUpperLimit":"0.98","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced RIR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of RIR was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced RIR within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.5"},{"groupId":"OG001","value":"1.6"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.418","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"1.14","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.83","ciUpperLimit":"1.58","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced UCR Within 2 Years From Randomization","description":"The time (in days) from study start to the first occurrence of UCR was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced UCR within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5"},{"groupId":"OG001","value":"3.8"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.493","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"1.07","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.88","ciUpperLimit":"1.31","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Died From Any Cause Within 2 Years From Randomization","description":"The time (in days) from study start to death from any cause was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). The Kaplan-Meier estimate reports the percentage of participants who died from any cause within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.1"},{"groupId":"OG001","value":"6.5"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.515","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"1.05","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.90","ciUpperLimit":"1.23","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]},{"type":"SECONDARY","title":"Kaplan-Meier Estimate of the Percentage of Participants Who Experienced a Stroke Within 2 Years From Randomization","description":"The time (in days) from study start to first experience of a stroke was recorded. A CEC reviewed and adjudicated each suspected efficacy endpoint event while blinded to treatment. Participants who did not have any endpoint event until last visit or participants who were lost to follow-up and had no event were censored at the time of last available information (last study visit). If a participant had a fatal event that was not part of a specific endpoint for analysis, they were censored at the time of death. The Kaplan-Meier estimate reports the percentage of participants who experienced a stroke within 2 years from randomization.","populationDescription":"Intent to Treat Population, defined as all participants who were randomly assigned to a treatment arm.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Percentage of Participants","timeFrame":"Up to 2 years","groups":[{"id":"OG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."},{"id":"OG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"6471"},{"groupId":"OG001","value":"6473"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.1"},{"groupId":"OG001","value":"1.9"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.606","statisticalMethod":"Cox Proportional Hazards Regression","statisticalComment":"Hazard Ratio calculated with covariates for treatment and stratification factors","paramType":"Cox Proportional Hazard","paramValue":"0.93","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.70","ciUpperLimit":"1.23","estimateComment":"Hazard ratio calculated by dividing the Kaplan-Meier (KM) Estimate for vorapaxar by the KM Estimate for Placebo and correcting for covariates. A hazard ratio \\<1 would indicate a lower hazard associated with vorapaxar relative to placebo."}]}]},"adverseEventsModule":{"frequencyThreshold":"5","description":"Adverse events are reported using the As Treated Population, which included all participants who received at least 1 dose of study medication and are reported according to treatment received.","eventGroups":[{"id":"EG000","title":"Placebo","description":"Loading oral dose of one 40 mg vorapaxar placebo tablet on Day 1, then one 2.5 mg vorapaxar placebo tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care.","seriousNumAffected":1718,"seriousNumAtRisk":6441,"otherNumAffected":832,"otherNumAtRisk":6441},{"id":"EG001","title":"Vorapaxar","description":"Loading oral dose of one 40 mg vorapaxar tablet on Day 1, then one 2.5 mg vorapaxar tablet daily, orally for at least 1 year in addition to current treatment of acute coronary syndrome, which will be continued to be administered as per current stand of care.","seriousNumAffected":1866,"seriousNumAtRisk":6446,"otherNumAffected":1081,"otherNumAtRisk":6446}],"seriousEvents":[{"term":"ANAEMIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":29,"numAffected":28,"numAtRisk":6441},{"groupId":"EG001","numEvents":59,"numAffected":55,"numAtRisk":6446}]},{"term":"COAGULOPATHY","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"DISSEMINATED INTRAVASCULAR COAGULATION","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"EOSINOPHILIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"FEBRILE NEUTROPENIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GRANULOCYTOPENIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HAEMORRHAGIC ANAEMIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"HAEMORRHAGIC DIATHESIS","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":6446}]},{"term":"HEPARIN-INDUCED THROMBOCYTOPENIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPOCHROMIC ANAEMIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":6446}]},{"term":"IDIOPATHIC THROMBOCYTOPENIC PURPURA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"IRON DEFICIENCY ANAEMIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":6446}]},{"term":"LEUKOCYTOSIS","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LYMPHADENOPATHY","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LYMPHADENOPATHY MEDIASTINAL","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MICROCYTIC ANAEMIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"NORMOCHROMIC NORMOCYTIC ANAEMIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SPLENIC INFARCTION","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SPONTANEOUS HAEMATOMA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"THROMBOCYTOPENIA","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":34,"numAffected":34,"numAtRisk":6441},{"groupId":"EG001","numEvents":30,"numAffected":30,"numAtRisk":6446}]},{"term":"THROMBOCYTOSIS","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"ANGINA PECTORIS","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"ANGINA UNSTABLE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"AORTIC VALVE DISEASE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"AORTIC VALVE INCOMPETENCE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"AORTIC VALVE STENOSIS","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"ARRHYTHMIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"ARRHYTHMIA SUPRAVENTRICULAR","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":3,"numAtRisk":6446}]},{"term":"ARTERIOSCLEROSIS CORONARY ARTERY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ARTERIOSPASM CORONARY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ATRIAL FIBRILLATION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":100,"numAffected":93,"numAtRisk":6441},{"groupId":"EG001","numEvents":113,"numAffected":96,"numAtRisk":6446}]},{"term":"ATRIAL FLUTTER","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":17,"numAffected":17,"numAtRisk":6441},{"groupId":"EG001","numEvents":18,"numAffected":17,"numAtRisk":6446}]},{"term":"ATRIAL RUPTURE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ATRIAL THROMBOSIS","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ATRIOVENTRICULAR BLOCK","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"ATRIOVENTRICULAR BLOCK COMPLETE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"ATRIOVENTRICULAR BLOCK SECOND DEGREE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"ATRIOVENTRICULAR DISSOCIATION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BIFASCICULAR BLOCK","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BRADYARRHYTHMIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BRADYCARDIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":26,"numAffected":26,"numAtRisk":6441},{"groupId":"EG001","numEvents":14,"numAffected":14,"numAtRisk":6446}]},{"term":"BUNDLE BRANCH BLOCK LEFT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CARDIAC ARREST","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"CARDIAC ASTHMA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CARDIAC FAILURE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":191,"numAffected":146,"numAtRisk":6441},{"groupId":"EG001","numEvents":191,"numAffected":142,"numAtRisk":6446}]},{"term":"CARDIAC FAILURE ACUTE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CARDIAC FAILURE CHRONIC","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CARDIAC FAILURE CONGESTIVE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":46,"numAffected":35,"numAtRisk":6441},{"groupId":"EG001","numEvents":53,"numAffected":45,"numAtRisk":6446}]},{"term":"CARDIAC HYPERTROPHY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CARDIAC PERFORATION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CARDIAC TAMPONADE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"CARDIAC VALVE DISEASE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CARDIO-RESPIRATORY ARREST","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"CARDIOGENIC SHOCK","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":41,"numAffected":39,"numAtRisk":6441},{"groupId":"EG001","numEvents":24,"numAffected":24,"numAtRisk":6446}]},{"term":"CARDIOMEGALY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CARDIOMYOPATHY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CARDIOPULMONARY FAILURE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"CARDIOVASCULAR INSUFFICIENCY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CHORDAE TENDINAE RUPTURE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CONGESTIVE CARDIOMYOPATHY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COR PULMONALE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CORONARY ARTERY DISEASE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"CORONARY ARTERY DISSECTION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CORONARY ARTERY INSUFFICIENCY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CORONARY ARTERY OCCLUSION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DRESSLER'S SYNDROME","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"EXTRASYSTOLES","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTROCARDIAC SYNDROME","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HEART VALVE CALCIFICATION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INTRACARDIAC THROMBUS","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"ISCHAEMIC CARDIOMYOPATHY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"LEFT VENTRICULAR DYSFUNCTION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"LEFT VENTRICULAR FAILURE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":6446}]},{"term":"MITRAL VALVE INCOMPETENCE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"MYOCARDIAL RUPTURE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MYOCARDITIS","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MYOPERICARDITIS","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NODAL ARRHYTHMIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NODAL RHYTHM","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PALPITATIONS","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":6446}]},{"term":"PAPILLARY MUSCLE RUPTURE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PERICARDIAL EFFUSION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"PERICARDIAL HAEMORRHAGE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":6441},{"groupId":"EG001","numEvents":19,"numAffected":18,"numAtRisk":6446}]},{"term":"PERICARDITIS","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"PERICARDITIS CONSTRICTIVE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PLEUROPERICARDITIS","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PRINZMETAL ANGINA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PULSELESS ELECTRICAL ACTIVITY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"RESTRICTIVE CARDIOMYOPATHY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":6446}]},{"term":"RIGHT VENTRICULAR DYSFUNCTION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RIGHT VENTRICULAR FAILURE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SICK SINUS SYNDROME","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":7,"numAtRisk":6446}]},{"term":"SINOATRIAL BLOCK","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SINUS ARREST","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SINUS ARRHYTHMIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SINUS BRADYCARDIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"SINUS TACHYCARDIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"STRESS CARDIOMYOPATHY","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SUPRAVENTRICULAR TACHYARRHYTHMIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SUPRAVENTRICULAR TACHYCARDIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":15,"numAffected":15,"numAtRisk":6441},{"groupId":"EG001","numEvents":11,"numAffected":9,"numAtRisk":6446}]},{"term":"TACHYCARDIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":6446}]},{"term":"TORSADE DE POINTES","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TRICUSPID VALVE INCOMPETENCE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"TRIFASCICULAR BLOCK","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VENTRICLE RUPTURE","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VENTRICULAR ARRHYTHMIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"VENTRICULAR DYSFUNCTION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VENTRICULAR EXTRASYSTOLES","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"VENTRICULAR FIBRILLATION","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":33,"numAffected":28,"numAtRisk":6441},{"groupId":"EG001","numEvents":32,"numAffected":30,"numAtRisk":6446}]},{"term":"VENTRICULAR TACHYARRHYTHMIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VENTRICULAR TACHYCARDIA","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":41,"numAffected":36,"numAtRisk":6441},{"groupId":"EG001","numEvents":29,"numAffected":23,"numAtRisk":6446}]},{"term":"ARTERIOVENOUS MALFORMATION","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ATRIAL SEPTAL DEFECT","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL ANGIODYSPLASIA","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL ANGIODYSPLASIA HAEMORRHAGIC","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL ARTERIOVENOUS MALFORMATION","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYDROCELE","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PHIMOSIS","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DEAFNESS","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DEAFNESS NEUROSENSORY","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"EAR HAEMORRHAGE","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SUDDEN HEARING LOSS","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"TINNITUS","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VERTIGO","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"VERTIGO POSITIONAL","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VESTIBULAR DISORDER","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ADRENAL INSUFFICIENCY","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GOITRE","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPERTHYROIDISM","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HYPOTHYROIDISM","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TOXIC NODULAR GOITRE","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ABNORMAL SENSATION IN EYE","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CATARACT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":6446}]},{"term":"CONJUNCTIVITIS","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DIPLOPIA","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"EYE HAEMORRHAGE","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GLAUCOMA","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MACULAR HOLE","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OPTIC ISCHAEMIC NEUROPATHY","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RETINAL ARTERY OCCLUSION","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"RETINAL DETACHMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RETINAL VASCULAR THROMBOSIS","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"STRABISMUS","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ULCERATIVE KERATITIS","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VISUAL IMPAIRMENT","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ABDOMINAL DISCOMFORT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ABDOMINAL HERNIA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ABDOMINAL PAIN","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":15,"numAffected":11,"numAtRisk":6441},{"groupId":"EG001","numEvents":12,"numAffected":11,"numAtRisk":6446}]},{"term":"ABDOMINAL PAIN UPPER","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"ABDOMINAL STRANGULATED HERNIA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ABDOMINAL WALL HAEMATOMA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ACUTE ABDOMEN","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ANAL FISTULA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ANAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ASCITES","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COELIAC DISEASE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COLITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"COLITIS ISCHAEMIC","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"COLITIS ULCERATIVE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COLONIC POLYP","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"CONSTIPATION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"CROHN'S DISEASE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"DIABETIC GASTROPARESIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DIARRHOEA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":8,"numAtRisk":6446}]},{"term":"DIARRHOEA HAEMORRHAGIC","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DIVERTICULAR PERFORATION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DIVERTICULUM","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DIVERTICULUM INTESTINAL","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DIVERTICULUM INTESTINAL HAEMORRHAGIC","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DUODENAL ULCER","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DUODENAL ULCER HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"DUODENITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DYSPEPSIA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"DYSPHAGIA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ENTERITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ENTEROVESICAL FISTULA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"EROSIVE OESOPHAGITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"FAECALOMA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"FOOD POISONING","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"GASTRIC HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":6446}]},{"term":"GASTRIC POLYPS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GASTRIC ULCER","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"GASTRIC ULCER HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"GASTRIC ULCER PERFORATION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GASTRIC VARICES HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTRITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":14,"numAffected":14,"numAtRisk":6446}]},{"term":"GASTRITIS EROSIVE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"GASTRITIS HAEMORRHAGIC","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"GASTRODUODENITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL DISORDER","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL EROSION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":13,"numAtRisk":6441},{"groupId":"EG001","numEvents":28,"numAffected":26,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL NECROSIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL PERFORATION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL ULCER","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTROOESOPHAGEAL REFLUX DISEASE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"GINGIVAL BLEEDING","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HAEMATEMESIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":6441},{"groupId":"EG001","numEvents":12,"numAffected":12,"numAtRisk":6446}]},{"term":"HAEMATOCHEZIA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":6446}]},{"term":"HAEMORRHAGIC EROSIVE GASTRITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HAEMORRHOIDAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"HAEMORRHOIDS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPERCHLORHYDRIA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ILEUS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"ILEUS PARALYTIC","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INGUINAL HERNIA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":16,"numAffected":16,"numAtRisk":6446}]},{"term":"INGUINAL HERNIA, OBSTRUCTIVE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INTESTINAL HAEMATOMA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INTESTINAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INTESTINAL ISCHAEMIA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"INTESTINAL OBSTRUCTION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"INTESTINAL PERFORATION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LARGE INTESTINAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LARGE INTESTINAL OBSTRUCTION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LOCALISED INTRAABDOMINAL FLUID COLLECTION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LOWER GASTROINTESTINAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"MECHANICAL ILEUS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MELAENA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":28,"numAffected":26,"numAtRisk":6441},{"groupId":"EG001","numEvents":40,"numAffected":38,"numAtRisk":6446}]},{"term":"MESENTERIC VEIN THROMBOSIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NAUSEA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OESOPHAGEAL PERFORATION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"OESOPHAGEAL STENOSIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"OESOPHAGEAL ULCER","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"OESOPHAGEAL ULCER HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"OESOPHAGITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"OESOPHAGITIS HAEMORRHAGIC","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PANCREATIC CYST","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PANCREATITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":6446}]},{"term":"PANCREATITIS ACUTE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"PEPTIC ULCER","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"PERIODONTITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PERITONEAL HAEMATOMA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PERITONITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PHARYNGOESOPHAGEAL DIVERTICULUM","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RECTAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":22,"numAffected":22,"numAtRisk":6441},{"groupId":"EG001","numEvents":29,"numAffected":26,"numAtRisk":6446}]},{"term":"REFLUX OESOPHAGITIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RETROPERITONEAL FIBROSIS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RETROPERITONEAL HAEMATOMA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RETROPERITONEAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"SMALL INTESTINAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SMALL INTESTINAL OBSTRUCTION","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SUBILEUS","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"TONGUE DISORDER","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TOOTHACHE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"UMBILICAL HERNIA","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"UMBILICAL HERNIA, OBSTRUCTIVE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"UPPER GASTROINTESTINAL HAEMORRHAGE","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":6446}]},{"term":"VOMITING","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"ASTHENIA","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"BLOODY DISCHARGE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CATHETER SITE HAEMATOMA","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":16,"numAtRisk":6441},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":6446}]},{"term":"CATHETER SITE HAEMORRHAGE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":17,"numAffected":17,"numAtRisk":6441},{"groupId":"EG001","numEvents":23,"numAffected":23,"numAtRisk":6446}]},{"term":"CHEST DISCOMFORT","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"CHEST PAIN","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":42,"numAffected":33,"numAtRisk":6441},{"groupId":"EG001","numEvents":30,"numAffected":29,"numAtRisk":6446}]},{"term":"CYST","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DEVICE BREAKAGE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DEVICE DISLOCATION","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"DEVICE MALFUNCTION","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"DRUG INTOLERANCE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"EXERCISE TOLERANCE DECREASED","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"FATIGUE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"GAIT DISTURBANCE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GENERAL PHYSICAL HEALTH DETERIORATION","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GENERALISED OEDEMA","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HERNIA","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HERNIA OBSTRUCTIVE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPOTHERMIA","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"IMPAIRED HEALING","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"INFLAMMATION","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INFLUENZA LIKE ILLNESS","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INJECTION SITE HAEMORRHAGE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LOCAL SWELLING","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MALAISE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MEDICAL DEVICE COMPLICATION","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MUCOSAL INFLAMMATION","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MULTI-ORGAN DISORDER","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"MULTI-ORGAN FAILURE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"NECROSIS","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NON-CARDIAC CHEST PAIN","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":127,"numAffected":112,"numAtRisk":6441},{"groupId":"EG001","numEvents":158,"numAffected":141,"numAtRisk":6446}]},{"term":"OEDEMA PERIPHERAL","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"PAIN","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"POLYP","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PUNCTURE SITE REACTION","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PYREXIA","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"SECRETION DISCHARGE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SENSATION OF PRESSURE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SUDDEN CARDIAC DEATH","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"THROMBOSIS IN DEVICE","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ULCER","organSystem":"General disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ACUTE HEPATIC FAILURE","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BILE DUCT OBSTRUCTION","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BILE DUCT STONE","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"BILIARY COLIC","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BILIARY DYSKINESIA","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CHOLANGITIS","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CHOLANGITIS ACUTE","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CHOLECYSTITIS","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":18,"numAffected":18,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"CHOLECYSTITIS ACUTE","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":6441},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":6446}]},{"term":"CHOLELITHIASIS","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":15,"numAffected":15,"numAtRisk":6441},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":6446}]},{"term":"GALLBLADDER DISORDER","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HEPATIC CIRRHOSIS","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HEPATIC FAILURE","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"HEPATIC STEATOSIS","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HEPATITIS","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"HEPATITIS ACUTE","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HEPATITIS TOXIC","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"JAUNDICE","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LIVER DISORDER","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ALLERGY TO CHEMICALS","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"AMYLOIDOSIS","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ANAPHYLACTIC REACTION","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ANAPHYLACTIC SHOCK","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ANTIPHOSPHOLIPID SYNDROME","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CONTRAST MEDIA ALLERGY","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DRUG HYPERSENSITIVITY","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPERSENSITIVITY","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"SARCOIDOSIS","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ABDOMINAL ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"ABDOMINAL INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ABDOMINAL SEPSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ABSCESS LIMB","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ABSCESS ORAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ANAL ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"APPENDICITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"APPENDICITIS PERFORATED","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ARTERIOVENOUS GRAFT SITE INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ARTERITIS INFECTIVE","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ARTHRITIS INFECTIVE","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BACTERAEMIA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"BACTERIAL INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BACTERIAL SEPSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BORRELIA INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BRONCHITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":11,"numAtRisk":6441},{"groupId":"EG001","numEvents":18,"numAffected":18,"numAtRisk":6446}]},{"term":"BRONCHITIS VIRAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BRONCHOPNEUMONIA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"CELLULITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":16,"numAtRisk":6441},{"groupId":"EG001","numEvents":26,"numAffected":25,"numAtRisk":6446}]},{"term":"CHEST WALL ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CHOLECYSTITIS INFECTIVE","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CLOSTRIDIAL INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CLOSTRIDIUM DIFFICILE COLITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CYSTITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"CYTOMEGALOVIRUS INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DEVICE RELATED INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DIABETIC FOOT INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DIVERTICULITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":8,"numAtRisk":6441},{"groupId":"EG001","numEvents":14,"numAffected":13,"numAtRisk":6446}]},{"term":"ENDOCARDITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"ENTEROCOCCAL INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ENTEROCOCCAL SEPSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ERYSIPELAS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":6446}]},{"term":"ESCHERICHIA SEPSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ESCHERICHIA URINARY TRACT INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"EYE INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GANGRENE","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GASTROENTERITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":8,"numAtRisk":6441},{"groupId":"EG001","numEvents":13,"numAffected":12,"numAtRisk":6446}]},{"term":"GASTROENTERITIS NOROVIRUS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GASTROENTERITIS SALMONELLA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTROENTERITIS VIRAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"GRAFT INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"GROIN ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GROIN INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"H1N1 INFLUENZA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HAEMATOMA INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HEPATITIS B","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HEPATITIS C","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HERPES SIMPLEX","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HERPES ZOSTER","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"HIV INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"IMPLANT SITE INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INCISION SITE INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"INFECTED CYST","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INFECTED SEBACEOUS CYST","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INFECTED SKIN ULCER","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":6446}]},{"term":"INFLUENZA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"INJECTION SITE ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INTERVERTEBRAL DISCITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"KIDNEY INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LEISHMANIASIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LEPROSY","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LIP INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LOBAR PNEUMONIA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"LOCALISED INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"LOWER RESPIRATORY TRACT INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"LUNG INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LUNG INFECTION PSEUDOMONAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LYMPH NODE ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MEDIASTINITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"MENINGITIS ASEPTIC","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"METAPNEUMOVIRUS INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NECROTISING FASCIITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NOCARDIOSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ORCHITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"OSTEOMYELITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"OSTEOMYELITIS CHRONIC","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OTITIS MEDIA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"OTITIS MEDIA CHRONIC","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PELVIC ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PERICARDITIS TUBERCULOUS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PERIDIVERTICULAR ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PERIRECTAL ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PERITONEAL ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PNEUMONIA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":93,"numAffected":83,"numAtRisk":6441},{"groupId":"EG001","numEvents":111,"numAffected":100,"numAtRisk":6446}]},{"term":"PNEUMONIA BACTERIAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PNEUMONIA HAEMOPHILUS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PNEUMONIA INFLUENZAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PNEUMONIA KLEBSIELLA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PNEUMONIA PNEUMOCOCCAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PNEUMONIA PRIMARY ATYPICAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"POST PROCEDURAL INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"POSTOPERATIVE WOUND INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"PSEUDOMEMBRANOUS COLITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":6446}]},{"term":"PSEUDOMONAS BRONCHITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PSOAS ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PYELONEPHRITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PYOTHORAX","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RESPIRATORY TRACT INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"RESPIRATORY TRACT INFECTION VIRAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SCROTAL ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SEPSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":23,"numAffected":23,"numAtRisk":6441},{"groupId":"EG001","numEvents":25,"numAffected":24,"numAtRisk":6446}]},{"term":"SEPTIC SHOCK","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":18,"numAffected":18,"numAtRisk":6441},{"groupId":"EG001","numEvents":11,"numAffected":11,"numAtRisk":6446}]},{"term":"SERRATIA INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SHUNT INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SIALOADENITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SINUSITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SKIN INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"SMALL INTESTINE GANGRENE","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"STAPHYLOCOCCAL ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"STAPHYLOCOCCAL BACTERAEMIA","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"STAPHYLOCOCCAL INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"STAPHYLOCOCCAL MEDIASTINITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"STAPHYLOCOCCAL SEPSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"STERNITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"STITCH ABSCESS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"STREPTOCOCCAL SEPSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"UPPER RESPIRATORY TRACT INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"URINARY TRACT INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":27,"numAffected":26,"numAtRisk":6441},{"groupId":"EG001","numEvents":25,"numAffected":23,"numAtRisk":6446}]},{"term":"UROSEPSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":6446}]},{"term":"VESTIBULAR NEURONITIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"VIRAL INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"VIRAL UPPER RESPIRATORY TRACT INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"WOUND INFECTION","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"WOUND INFECTION STAPHYLOCOCCAL","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"WOUND SEPSIS","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ABDOMINAL INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ABDOMINAL WOUND DEHISCENCE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ACCIDENTAL OVERDOSE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ALCOHOL POISONING","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"ANAEMIA POSTOPERATIVE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ANKLE FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"ARTERIAL INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ARTERIOVENOUS FISTULA SITE HAEMORRHAGE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BACK INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CARDIAC PROCEDURE COMPLICATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CARDIAC VALVE RUPTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CEREBRAL HAEMORRHAGE TRAUMATIC","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CLAVICLE FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COLLAPSE OF LUNG","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"COMMINUTED FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CONCUSSION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CONFUSION POSTOPERATIVE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CONTUSION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":6,"numAtRisk":6446}]},{"term":"CRUSH INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"EXTRADURAL HAEMATOMA","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"FACE INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"FACIAL BONES FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"FALL","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":16,"numAtRisk":6441},{"groupId":"EG001","numEvents":22,"numAffected":22,"numAtRisk":6446}]},{"term":"FEMORAL NECK FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"FEMUR FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"FIBULA FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"FOOT FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"FOREARM FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL STOMA COMPLICATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GUN SHOT WOUND","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HEAD INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"HEPATIC HAEMATOMA","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HEPATIC RUPTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HIP FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"HUMERUS FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"INCISION SITE COMPLICATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INCISION SITE HAEMORRHAGE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INCISIONAL HERNIA","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INFLAMMATION OF WOUND","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"JOINT DISLOCATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LACERATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LIMB INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"LIMB TRAUMATIC AMPUTATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LUMBAR VERTEBRAL FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"MENISCUS LESION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MULTIPLE FRACTURES","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MUSCLE STRAIN","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"OPEN FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OPERATIVE HAEMORRHAGE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":11,"numAtRisk":6441},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":6446}]},{"term":"OVERDOSE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"PATELLA FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"PELVIC FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PERIPROSTHETIC FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"POST PROCEDURAL COMPLICATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"POST PROCEDURAL DISCHARGE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"POST PROCEDURAL HAEMATOMA","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"POST PROCEDURAL HAEMORRHAGE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":91,"numAffected":91,"numAtRisk":6441},{"groupId":"EG001","numEvents":114,"numAffected":112,"numAtRisk":6446}]},{"term":"POSTOPERATIVE HERNIA","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"POSTOPERATIVE ILEUS","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"POSTOPERATIVE THORACIC PROCEDURE COMPLICATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"POSTOPERATIVE WOUND COMPLICATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"POSTPERICARDIOTOMY SYNDROME","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"PROCEDURAL PAIN","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"PUBIS FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RADIUS FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"RIB FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"ROAD TRAFFIC ACCIDENT","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":7,"numAtRisk":6446}]},{"term":"SHUNT MALFUNCTION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SKULL FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SKULL FRACTURED BASE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SOFT TISSUE INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SPINAL COMPRESSION FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":6446}]},{"term":"SPINAL FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SPLENIC RUPTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"STAB WOUND","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"STERNAL FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SUBDURAL HAEMATOMA","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"SUBDURAL HAEMORRHAGE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"TENDON INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TENDON RUPTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"THERMAL BURN","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TIBIA FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"TOXICITY TO VARIOUS AGENTS","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"TRANSPLANT FAILURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TRAUMATIC LIVER INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"TRAUMATIC LUNG INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"UPPER LIMB FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"URINARY RETENTION POSTOPERATIVE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VASCULAR PROCEDURE COMPLICATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VASCULAR PSEUDOANEURYSM","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":17,"numAffected":17,"numAtRisk":6446}]},{"term":"VASOPLEGIA SYNDROME","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VENA CAVA INJURY","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"WOUND","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"WOUND COMPLICATION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"WOUND DEHISCENCE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"WOUND HAEMORRHAGE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"WOUND SECRETION","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"WRIST FRACTURE","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ALANINE AMINOTRANSFERASE INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLEEDING TIME PROLONGED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLOOD ALKALINE PHOSPHATASE INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BLOOD BILIRUBIN INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLOOD CREATINE PHOSPHOKINASE INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLOOD CREATINE PHOSPHOKINASE MB INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLOOD CREATININE INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLOOD CULTURE POSITIVE","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BLOOD GLUCOSE ABNORMAL","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLOOD GLUCOSE INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":6446}]},{"term":"BLOOD POTASSIUM DECREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLOOD PRESSURE INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"C-REACTIVE PROTEIN INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CARDIAC MONITORING ABNORMAL","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CAROTID BRUIT","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"EJECTION FRACTION DECREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"ELECTROCARDIOGRAM QRS COMPLEX PROLONGED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GAMMA-GLUTAMYLTRANSFERASE INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HAEMOGLOBIN DECREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":6441},{"groupId":"EG001","numEvents":12,"numAffected":12,"numAtRisk":6446}]},{"term":"HEART RATE IRREGULAR","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HEPATIC ENZYME INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"LIPOPROTEIN (A) INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LIVER FUNCTION TEST ABNORMAL","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OCCULT BLOOD POSITIVE","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"PLATELET COUNT DECREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"TRANSAMINASES INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TROPONIN INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"URINE OUTPUT DECREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"WEIGHT DECREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"WEIGHT INCREASED","organSystem":"Investigations","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CACHEXIA","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DEHYDRATION","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":7,"numAtRisk":6446}]},{"term":"DIABETES MELLITUS","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":11,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"DIABETES MELLITUS INADEQUATE CONTROL","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"DIABETIC FOOT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"DIABETIC KETOACIDOSIS","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":3,"numAtRisk":6446}]},{"term":"ELECTROLYTE IMBALANCE","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"FAILURE TO THRIVE","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"FLUID OVERLOAD","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"FLUID RETENTION","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GOUT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"HYPERGLYCAEMIA","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HYPERKALAEMIA","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":9,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"HYPOCALCAEMIA","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPOGLYCAEMIA","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":11,"numAffected":11,"numAtRisk":6441},{"groupId":"EG001","numEvents":12,"numAffected":10,"numAtRisk":6446}]},{"term":"HYPOGLYCAEMIC UNCONSCIOUSNESS","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HYPOKALAEMIA","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"HYPONATRAEMIA","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"IRON DEFICIENCY","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LACTIC ACIDOSIS","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"OBESITY","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TYPE 2 DIABETES MELLITUS","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ARTHRALGIA","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"ARTHRITIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"ARTHRITIS REACTIVE","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ARTHROPATHY","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ARTICULAR CALCIFICATION","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BACK PAIN","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":8,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":6446}]},{"term":"BONE PAIN","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BURSITIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CERVICAL SPINAL STENOSIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CHONDRITIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"COMPARTMENT SYNDROME","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CRYSTAL ARTHROPATHY","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GROIN PAIN","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HAEMARTHROSIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INTERVERTEBRAL DISC PROTRUSION","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"JOINT EFFUSION","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"KYPHOSIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LUMBAR SPINAL STENOSIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"MUSCLE HAEMORRHAGE","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MUSCLE TIGHTNESS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MUSCULAR WEAKNESS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MUSCULOSKELETAL CHEST PAIN","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":19,"numAffected":19,"numAtRisk":6441},{"groupId":"EG001","numEvents":16,"numAffected":14,"numAtRisk":6446}]},{"term":"MUSCULOSKELETAL PAIN","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":10,"numAffected":10,"numAtRisk":6446}]},{"term":"MYALGIA","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":4,"numAtRisk":6446}]},{"term":"MYALGIA INTERCOSTAL","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MYOPATHY","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MYOSCLEROSIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NECK PAIN","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"OSTEOARTHRITIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":22,"numAffected":22,"numAtRisk":6441},{"groupId":"EG001","numEvents":16,"numAffected":16,"numAtRisk":6446}]},{"term":"OSTEONECROSIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PAIN IN EXTREMITY","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":6446}]},{"term":"POLYARTHRITIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RHABDOMYOLYSIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RHEUMATOID ARTHRITIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ROTATOR CUFF SYNDROME","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SCOLIOSIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SPINAL COLUMN STENOSIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"SPINAL DISORDER","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SPONDYLOLISTHESIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SYMPATHETIC POSTERIOR CERVICAL SYNDROME","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SYNOVIAL CYST","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"TENDONITIS","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TRIGGER FINGER","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ABDOMINAL NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ADENOCARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ADRENAL ADENOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ADRENAL NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"B-CELL LYMPHOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BASAL CELL CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"BENIGN LUNG NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BENIGN NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BENIGN NEOPLASM OF BLADDER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BENIGN OESOPHAGEAL NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BILE DUCT CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLADDER CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"BLADDER NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":4,"numAtRisk":6446}]},{"term":"BLADDER TRANSITIONAL CELL CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BRAIN NEOPLASM BENIGN","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BREAST CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"BREAST NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BRONCHIAL CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CANCER PAIN","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CARDIAC VALVE FIBROELASTOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CEREBRAL HAEMANGIOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CHRONIC LYMPHOCYTIC LEUKAEMIA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CHRONIC MYELOMONOCYTIC LEUKAEMIA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COLON ADENOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COLON CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":6441},{"groupId":"EG001","numEvents":20,"numAffected":20,"numAtRisk":6446}]},{"term":"COLON CANCER STAGE II","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COLON CANCER STAGE III","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"COLON NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"COLORECTAL CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ENDOMETRIAL CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ENDOMETRIAL CANCER STAGE I","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"ENDOMETRIAL NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"FIBROMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTRIC CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"GASTRIC CANCER STAGE 0","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTRIC NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL CANCER METASTATIC","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"GASTROINTESTINAL TRACT ADENOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"GASTROOESOPHAGEAL CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HEPATIC NEOPLASM MALIGNANT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HODGKIN'S DISEASE","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HODGKIN'S DISEASE MIXED CELLULARITY STAGE UNSPECIFIED","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INTESTINAL ADENOCARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INTRAOCULAR MELANOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"IRITIC MELANOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LARGE CELL CARCINOMA OF THE RESPIRATORY TRACT STAGE UNSPECIFIED","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LARYNGEAL CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LIPOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LUNG ADENOCARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LUNG ADENOCARCINOMA METASTATIC","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LUNG CANCER METASTATIC","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LUNG NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"LUNG NEOPLASM MALIGNANT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":6446}]},{"term":"LUNG SQUAMOUS CELL CARCINOMA STAGE III","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LYMPHOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MALIGNANT GLIOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MALIGNANT MELANOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":3,"numAtRisk":6446}]},{"term":"MEDIASTINUM NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"METASTASES TO BONE","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"METASTASES TO CENTRAL NERVOUS SYSTEM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"METASTASES TO LARYNX","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"METASTASES TO LIVER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"METASTASES TO LUNG","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"METASTASES TO LYMPH NODES","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"METASTATIC MALIGNANT MELANOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"METASTATIC NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"METASTATIC RENAL CELL CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"METASTATIC SQUAMOUS CELL CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MYELODYSPLASTIC SYNDROME","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NASAL CAVITY CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NEOPLASM MALIGNANT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NEUROENDOCRINE CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NON-SMALL CELL LUNG CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"OESOPHAGEAL CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"OESOPHAGEAL CARCINOMA RECURRENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OVARIAN CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OVARIAN CANCER METASTATIC","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"OVARIAN NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PAGET'S DISEASE OF SKIN","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PANCREATIC CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"PAPILLOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PHAEOCHROMOCYTOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PITUITARY TUMOUR BENIGN","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PROSTATE CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":8,"numAffected":7,"numAtRisk":6446}]},{"term":"PROSTATE CANCER METASTATIC","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"PROSTATE CANCER RECURRENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PROSTATIC ADENOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RECTAL ADENOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RECTAL CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RECTAL NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RENAL CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RENAL CANCER RECURRENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RENAL CELL CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"RENAL CELL CARCINOMA RECURRENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RENAL NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RENAL ONCOCYTOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SARCOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SMALL CELL LUNG CANCER STAGE UNSPECIFIED","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SMALL INTESTINE CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SQUAMOUS CELL CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"SQUAMOUS CELL CARCINOMA OF SKIN","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"T-CELL LYMPHOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"TESTIS CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"THYROID NEOPLASM","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TRANSITIONAL CELL CARCINOMA","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"UTERINE CANCER","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ALCOHOLIC SEIZURE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ATAXIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BRACHIAL PLEXOPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BRAIN MASS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BRAIN OEDEMA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CAROTID ARTERY DISEASE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"CAROTID ARTERY OCCLUSION","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CAROTID ARTERY STENOSIS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":11,"numAtRisk":6441},{"groupId":"EG001","numEvents":18,"numAffected":17,"numAtRisk":6446}]},{"term":"CARPAL TUNNEL SYNDROME","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CEREBELLAR HAEMORRHAGE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CEREBRAL HAEMORRHAGE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"CEREBRAL HYPOPERFUSION","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CERVICOBRACHIAL SYNDROME","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CLUSTER HEADACHE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COMA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CONVULSION","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":6,"numAtRisk":6446}]},{"term":"CRANIAL NERVE PARALYSIS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CRITICAL ILLNESS POLYNEUROPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DEMENTIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DEMENTIA ALZHEIMER'S TYPE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DEMENTIA WITH LEWY BODIES","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DEPRESSED LEVEL OF CONSCIOUSNESS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DIABETIC NEUROPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DIZZINESS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":10,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"DYSAESTHESIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DYSARTHRIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ENCEPHALOPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"EPILEPSY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GRAND MAL CONVULSION","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":6446}]},{"term":"HAEMORRHAGE INTRACRANIAL","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":12,"numAtRisk":6441},{"groupId":"EG001","numEvents":35,"numAffected":33,"numAtRisk":6446}]},{"term":"HAEMORRHAGIC STROKE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HAEMORRHAGIC TRANSFORMATION STROKE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"HEADACHE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"HEMIPARESIS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HEPATIC ENCEPHALOPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPERTENSIVE ENCEPHALOPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HYPOAESTHESIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HYPOKINESIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPOTONIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPOXIC-ISCHAEMIC ENCEPHALOPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"INTERCOSTAL NEURALGIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INTRACRANIAL ANEURYSM","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LETHARGY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LOSS OF CONSCIOUSNESS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MENTAL IMPAIRMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MIGRAINE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MYASTHENIA GRAVIS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MYELOPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NERVE COMPRESSION","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"NERVE DEGENERATION","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NERVE ROOT COMPRESSION","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NERVOUS SYSTEM DISORDER","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NEURITIS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NEUROMYOPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NEUROPATHY PERIPHERAL","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NORMAL PRESSURE HYDROCEPHALUS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PARAESTHESIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PARAPARESIS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PARKINSON'S DISEASE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PARTIAL SEIZURES","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PERONEAL NERVE PALSY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PHRENIC NERVE PARALYSIS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PRESYNCOPE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"PSYCHOMOTOR HYPERACTIVITY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SCIATICA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SEDATION","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SENSORIMOTOR DISORDER","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SENSORY LOSS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SPINAL CORD COMPRESSION","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SPONDYLITIC MYELOPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SUBARACHNOID HAEMORRHAGE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"SUBDURAL HYGROMA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SYNCOPE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":48,"numAffected":48,"numAtRisk":6441},{"groupId":"EG001","numEvents":48,"numAffected":44,"numAtRisk":6446}]},{"term":"SYRINGOMYELIA","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"TREMOR","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VASCULAR ENCEPHALOPATHY","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"VERTEBRAL ARTERY STENOSIS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VIITH NERVE PARALYSIS","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ABNORMAL BEHAVIOUR","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ADJUSTMENT DISORDER WITH MIXED DISTURBANCE OF EMOTION AND CONDUCT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"AGITATION","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ALCOHOL ABUSE","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ALCOHOL WITHDRAWAL SYNDROME","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"ALCOHOLISM","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ANXIETY","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"ANXIETY DISORDER","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BIPOLAR I DISORDER","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COMPLETED SUICIDE","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CONFUSIONAL STATE","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"DELIRIUM","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"DEPRESSION","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":8,"numAtRisk":6441},{"groupId":"EG001","numEvents":15,"numAffected":11,"numAtRisk":6446}]},{"term":"HALLUCINATION","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HALLUCINATION, VISUAL","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"MAJOR DEPRESSION","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":6446}]},{"term":"MENTAL STATUS CHANGES","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"PANIC ATTACK","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PSYCHOTIC DISORDER","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SUBSTANCE ABUSE","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SUICIDAL IDEATION","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"SUICIDE ATTEMPT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"TOBACCO WITHDRAWAL SYMPTOMS","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BLADDER DYSFUNCTION","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CALCULUS BLADDER","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CALCULUS URETERIC","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"CALCULUS URINARY","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"HAEMATURIA","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":15,"numAtRisk":6441},{"groupId":"EG001","numEvents":37,"numAffected":31,"numAtRisk":6446}]},{"term":"HAEMORRHAGE URINARY TRACT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":5,"numAtRisk":6446}]},{"term":"HYDRONEPHROSIS","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NEPHROLITHIASIS","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"NEPHROPATHY","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NEPHROPATHY TOXIC","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NEPHROTIC SYNDROME","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"NEUROGENIC BLADDER","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"OBSTRUCTIVE UROPATHY","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"POLYURIA","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RENAL ANEURYSM","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RENAL ARTERY OCCLUSION","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RENAL ARTERY STENOSIS","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"RENAL COLIC","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"RENAL CYST","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RENAL DISORDER","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RENAL FAILURE","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":55,"numAffected":50,"numAtRisk":6441},{"groupId":"EG001","numEvents":61,"numAffected":56,"numAtRisk":6446}]},{"term":"RENAL FAILURE ACUTE","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":38,"numAffected":36,"numAtRisk":6441},{"groupId":"EG001","numEvents":39,"numAffected":38,"numAtRisk":6446}]},{"term":"RENAL FAILURE CHRONIC","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":8,"numAtRisk":6446}]},{"term":"RENAL IMPAIRMENT","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"RENAL MASS","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RENAL TUBULAR NECROSIS","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"STRESS URINARY INCONTINENCE","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"TUBULOINTERSTITIAL NEPHRITIS","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"URINARY RETENTION","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"URINARY TRACT OBSTRUCTION","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BENIGN PROSTATIC HYPERPLASIA","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"BREAST INFLAMMATION","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"CYSTOCELE","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"EPIDIDYMITIS","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"GENITAL HAEMORRHAGE","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OVARIAN CYST","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PELVIC FLUID COLLECTION","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"POSTMENOPAUSAL HAEMORRHAGE","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"PROSTATITIS","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":6446}]},{"term":"PROSTATOMEGALY","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RECTOCELE","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"UTERINE ENLARGEMENT","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"UTERINE PROLAPSE","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VAGINAL PROLAPSE","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ACUTE PULMONARY OEDEMA","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":6441},{"groupId":"EG001","numEvents":14,"numAffected":14,"numAtRisk":6446}]},{"term":"ACUTE RESPIRATORY DISTRESS SYNDROME","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"ACUTE RESPIRATORY FAILURE","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":16,"numAtRisk":6441},{"groupId":"EG001","numEvents":16,"numAffected":15,"numAtRisk":6446}]},{"term":"ALLERGIC GRANULOMATOUS ANGIITIS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ALVEOLITIS ALLERGIC","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"APNOEA","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ASPIRATION","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ASTHMA","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"ATELECTASIS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"BRONCHIAL HYPERREACTIVITY","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"BRONCHIAL OBSTRUCTION","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"BRONCHITIS CHRONIC","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"BRONCHOSPASM","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"CHRONIC OBSTRUCTIVE PULMONARY DISEASE","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":71,"numAffected":51,"numAtRisk":6441},{"groupId":"EG001","numEvents":68,"numAffected":44,"numAtRisk":6446}]},{"term":"CHYLOTHORAX","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COUGH","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"DIAPHRAGMATIC HERNIA","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DIAPHRAGMATIC PARALYSIS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DYSPNOEA","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":20,"numAffected":20,"numAtRisk":6441},{"groupId":"EG001","numEvents":22,"numAffected":20,"numAtRisk":6446}]},{"term":"DYSPNOEA EXERTIONAL","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"DYSPNOEA PAROXYSMAL NOCTURNAL","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"EPISTAXIS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":9,"numAffected":9,"numAtRisk":6441},{"groupId":"EG001","numEvents":22,"numAffected":21,"numAtRisk":6446}]},{"term":"HAEMOPTYSIS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":8,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"HAEMOTHORAX","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"HICCUPS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HYDROTHORAX","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPERVENTILATION","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"INTERSTITIAL LUNG DISEASE","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LARYNGEAL OEDEMA","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LARYNGEAL STENOSIS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LUNG DISORDER","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LUNG INFILTRATION","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"NASAL POLYPS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OBSTRUCTIVE AIRWAYS DISORDER","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"OROPHARYNGEAL SWELLING","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PHARYNGEAL HAEMORRHAGE","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PLEURAL EFFUSION","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":31,"numAffected":30,"numAtRisk":6441},{"groupId":"EG001","numEvents":38,"numAffected":32,"numAtRisk":6446}]},{"term":"PLEURAL HAEMORRHAGE","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PLEURISY","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PLEURITIC PAIN","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"PNEUMONIA ASPIRATION","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"PNEUMONITIS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PNEUMOTHORAX","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"PULMONARY ALVEOLAR HAEMORRHAGE","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PULMONARY CONGESTION","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"PULMONARY EMBOLISM","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":34,"numAffected":34,"numAtRisk":6441},{"groupId":"EG001","numEvents":20,"numAffected":20,"numAtRisk":6446}]},{"term":"PULMONARY EOSINOPHILIA","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PULMONARY FIBROSIS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PULMONARY HAEMORRHAGE","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"PULMONARY HYPERTENSION","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PULMONARY MASS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"PULMONARY OEDEMA","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":12,"numAtRisk":6441},{"groupId":"EG001","numEvents":23,"numAffected":19,"numAtRisk":6446}]},{"term":"RESPIRATORY ARREST","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"RESPIRATORY DISTRESS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":6446}]},{"term":"RESPIRATORY FAILURE","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":27,"numAffected":26,"numAtRisk":6441},{"groupId":"EG001","numEvents":30,"numAffected":30,"numAtRisk":6446}]},{"term":"RESPIRATORY TRACT INFLAMMATION","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"RESTRICTIVE PULMONARY DISEASE","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SLEEP APNOEA SYNDROME","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"TONSILLAR HYPERTROPHY","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VOCAL CORD POLYP","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":6446}]},{"term":"ANGIOEDEMA","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DECUBITUS ULCER","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DERMATITIS","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DERMATITIS EXFOLIATIVE","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DIABETIC ULCER","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DRUG ERUPTION","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DYSHIDROSIS","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPERHIDROSIS","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"NEUROPATHIC ULCER","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PEMPHIGOID","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PEMPHIGUS","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PSORIASIS","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PURPURA","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"RASH","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"RASH MACULO-PAPULAR","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SKIN EXFOLIATION","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SKIN HAEMORRHAGE","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SKIN LESION","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SKIN NECROSIS","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"SKIN ULCER","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"STASIS DERMATITIS","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SUBCUTANEOUS EMPHYSEMA","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"URTICARIA","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CARDIAC OPERATION","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CATARACT OPERATION","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"DIABETES MELLITUS MANAGEMENT","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"WOUND DRAINAGE","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ACCELERATED HYPERTENSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ANEURYSM","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"AORTIC ANEURYSM","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":5,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":6,"numAtRisk":6446}]},{"term":"AORTIC ANEURYSM RUPTURE","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"AORTIC DISSECTION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"AORTIC DISSECTION RUPTURE","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"AORTIC RUPTURE","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"AORTIC STENOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":6446}]},{"term":"AORTIC THROMBOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ARTERIAL OCCLUSIVE DISEASE","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":4,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ARTERIAL STENOSIS LIMB","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ARTERIAL THROMBOSIS LIMB","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":6446}]},{"term":"ARTERIOSCLEROSIS OBLITERANS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"ARTERIOVENOUS FISTULA","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"CIRCULATORY COLLAPSE","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"COELIAC ARTERY OCCLUSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"DEEP VEIN THROMBOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":6441},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":6446}]},{"term":"DIABETIC MACROANGIOPATHY","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"EMBOLISM","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ESSENTIAL HYPERTENSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"FEMORAL ARTERIAL STENOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"FEMORAL ARTERY ANEURYSM","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"FEMORAL ARTERY DISSECTION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"FEMORAL ARTERY OCCLUSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"HAEMATOMA","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":7,"numAtRisk":6441},{"groupId":"EG001","numEvents":26,"numAffected":20,"numAtRisk":6446}]},{"term":"HAEMODYNAMIC INSTABILITY","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HAEMORRHAGE","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":12,"numAtRisk":6441},{"groupId":"EG001","numEvents":13,"numAffected":13,"numAtRisk":6446}]},{"term":"HYPERTENSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":25,"numAffected":23,"numAtRisk":6441},{"groupId":"EG001","numEvents":24,"numAffected":22,"numAtRisk":6446}]},{"term":"HYPERTENSIVE CRISIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":13,"numAtRisk":6441},{"groupId":"EG001","numEvents":21,"numAffected":20,"numAtRisk":6446}]},{"term":"HYPERTENSIVE EMERGENCY","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"HYPOTENSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":29,"numAffected":28,"numAtRisk":6441},{"groupId":"EG001","numEvents":29,"numAffected":29,"numAtRisk":6446}]},{"term":"HYPOVOLAEMIC SHOCK","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ILIAC ARTERY STENOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"INTERMITTENT CLAUDICATION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":16,"numAffected":14,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":9,"numAtRisk":6446}]},{"term":"INTRA-ABDOMINAL HAEMATOMA","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"JUGULAR VEIN THROMBOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"LABILE HYPERTENSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"LERICHE SYNDROME","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"MALIGNANT HYPERTENSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"ORTHOSTATIC HYPOTENSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":6441},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":6446}]},{"term":"PELVIC VENOUS THROMBOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PERIPHERAL ARTERIAL OCCLUSIVE DISEASE","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":12,"numAffected":11,"numAtRisk":6441},{"groupId":"EG001","numEvents":14,"numAffected":13,"numAtRisk":6446}]},{"term":"PERIPHERAL ARTERY ANEURYSM","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"PERIPHERAL ARTERY DISSECTION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PERIPHERAL EMBOLISM","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"PERIPHERAL ISCHAEMIA","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":9,"numAtRisk":6441},{"groupId":"EG001","numEvents":7,"numAffected":7,"numAtRisk":6446}]},{"term":"PERIPHERAL VASCULAR DISORDER","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":7,"numAffected":5,"numAtRisk":6441},{"groupId":"EG001","numEvents":9,"numAffected":8,"numAtRisk":6446}]},{"term":"PHLEBITIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"POOR PERIPHERAL CIRCULATION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"SHOCK","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":6446}]},{"term":"SHOCK HAEMORRHAGIC","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SUBCLAVIAN ARTERY STENOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"SUBCLAVIAN STEAL SYNDROME","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"TEMPORAL ARTERITIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":1,"numAtRisk":6446}]},{"term":"THROMBOANGIITIS OBLITERANS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"THROMBOPHLEBITIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"THROMBOPHLEBITIS SUPERFICIAL","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VARICOSE VEIN","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":6446}]},{"term":"VASCULAR INSUFFICIENCY","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VASCULAR STENOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VASCULITIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VASODILATATION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VENA CAVA THROMBOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":6446}]},{"term":"VENOUS THROMBOSIS","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]},{"term":"VENOUS THROMBOSIS LIMB","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":6441},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":6446}]}],"otherEvents":[{"term":"HEADACHE","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":424,"numAffected":385,"numAtRisk":6441},{"groupId":"EG001","numEvents":451,"numAffected":398,"numAtRisk":6446}]},{"term":"EPISTAXIS","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":293,"numAffected":228,"numAtRisk":6441},{"groupId":"EG001","numEvents":552,"numAffected":432,"numAtRisk":6446}]},{"term":"HYPERTENSION","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 14.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":359,"numAffected":310,"numAtRisk":6441},{"groupId":"EG001","numEvents":399,"numAffected":368,"numAtRisk":6446}]}]},"moreInfoModule":{"limitationsAndCaveats":{"description":"Prior to the planned study completion, the Data Safety Monitoring Board recommended that all participants stop treatment and that the study be closed-out. The protocol-defined target number of primary efficacy endpoints had been reached by this time."},"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"All draft publications will be submitted to the Publication Committee for review. Full-length papers will be submitted at least 45 days prior to submission to a journal. Abstracts or public presentations (eg, poster) will be submitted at least 14 days in advance."},"pointOfContact":{"title":"Senior Vice President, Global Clinical Development","organization":"Merck Sharp & Dohme Corp.","email":"ClinicalTrialsDisclosure@merck.com","phone":"1-800-672-6372"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14","removedCountries":["Argentina","Australia","Austria","Belgium","Brazil","Canada","Chile","China","Colombia","Czech Republic","Denmark","Finland","France","Germany","Hong Kong","Hungary","Israel","Italy","Japan","Korea, Republic of","Malaysia","Netherlands","Norway","Peru","Poland","Portugal","Puerto Rico","Singapore","South Africa","Spain","Sweden","Switzerland","Taiwan","Turkey","United Kingdom","United States"]},"conditionBrowseModule":{"meshes":[{"id":"D000009203","term":"Myocardial Infarction"},{"id":"D000054058","term":"Acute Coronary Syndrome"},{"id":"D000050197","term":"Atherosclerosis"},{"id":"D000017202","term":"Myocardial Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000009336","term":"Necrosis"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000001161","term":"Arteriosclerosis"},{"id":"D000001157","term":"Arterial Occlusive Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M6236","name":"Coronary Artery Disease","relevance":"LOW"},{"id":"M10233","name":"Ischemia","asFound":"Ischemia","relevance":"HIGH"},{"id":"M16045","name":"Syndrome","relevance":"LOW"},{"id":"M19196","name":"Myocardial Ischemia","asFound":"Myocardial Ischemia","relevance":"HIGH"},{"id":"M27235","name":"Acute Coronary Syndrome","asFound":"Acute Coronary Syndrome","relevance":"HIGH"},{"id":"M11845","name":"Myocardial Infarction","asFound":"Myocardial Infarction","relevance":"HIGH"},{"id":"M9972","name":"Infarction","asFound":"Infarction","relevance":"HIGH"},{"id":"M25878","name":"Atherosclerosis","asFound":"Atherosclerosis","relevance":"HIGH"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M4159","name":"Arteriosclerosis","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"C000530299","term":"Vorapaxar"}],"ancestors":[{"id":"D000010975","term":"Platelet Aggregation Inhibitors"}],"browseLeaves":[{"id":"M16366","name":"Thrombin","relevance":"LOW"},{"id":"M232590","name":"Vorapaxar","asFound":"Dose-Response Relationship","relevance":"HIGH"},{"id":"M13555","name":"Platelet Aggregation Inhibitors","relevance":"LOW"}],"browseBranches":[{"abbrev":"Coag","name":"Coagulants"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"}]}},"hasResults":true}